Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tackling benzodiazepine dependence in seniors: a new psychoeducational approach

NCT ID NCT06950567

Disease control Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This trial tests whether a multidisciplinary program combining psychoeducation and therapeutic exercise helps adults over 64 reduce or stop long-term benzodiazepine use. Participants receive a personalized letter from their doctor and are randomly assigned to either the letter alone or the letter plus an 8-week group program. The study tracks how many people completely stop or lower their dose over 6 and 18 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
psychoeducational intervention and therapeutic exercise
What this could lead to
If effective, this approach could provide a safe, drug-free way to help older adults reduce dependence on benzodiazepines.
What could go wrong
The trial is small (122 participants) and the intervention requires regular attendance, which may limit real-world uptake. Results may not apply to all older adults.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

122 people

The number who actually took part.

Started

Apr 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥65 years. * Current benzodiazepine use for ≥3 months. * Ability to provide written informed consent. Exclusion Criteria: * Severe psychiatric disorder, dementia, or epilepsy. * Enrollment in a home care program, institutionalization, or palliative care. * Language barriers or mobility limitations preventing attendance at the primary care centre.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Disminución del consumo benzodiacepinas are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Disminución del consumo benzodiacepinas Suspensión completa del tratamiento con benzodicepinas

Contacts and locations

Locations

  • Primary Care Team of Alfarràs-Almenar.

    Almenar, Lleida, 25126, Spain